Prader-Willi Syndrome — Research Summary
Printed from RareWays (rareways.com.au) on 5 April 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Dampened surge in heart rate at respiratory event termination in children with Prader-Willi syndrome.
Walter Lisa M et al. — Sleep medicine (1 May 2026)
https://pubmed.ncbi.nlm.nih.gov/41691910/
- 2.
A comparison of treadmill preferred walking speed assessments: Reliability of common protocols and the novel TreadPWS Test.
McDonald Kirsty A et al. — Gait & posture (1 May 2026)
https://pubmed.ncbi.nlm.nih.gov/41687575/
- 3.
Synergistically engineered porous wheat starch via sodium trimetaphosphate-sodium hypochlorite dual modification: Microstructural revelations and enhanced functional performance.
Chen Jun et al. — Food chemistry (15 April 2026)
https://pubmed.ncbi.nlm.nih.gov/41702005/
- 4.
Unravelling Narcolepsy: A Series of Complex Pediatric Cases.
Gnazzo Martina et al. — Neurology. Clinical practice (1 April 2026)
https://pubmed.ncbi.nlm.nih.gov/41669756/
- 5.
Form and Function: Stronger Toes and Shorter Heels Associate With Better Gait Performance.
Smith Ross E et al. — Journal of applied biomechanics (1 April 2026)
https://pubmed.ncbi.nlm.nih.gov/41569817/
Clinical Trials — Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials.
- 1.
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Recruiting — Phase 3 — Harmony Biosciences Management, Inc.
https://clinicaltrials.gov/study/NCT06366464
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Prader-Willi Syndrome
Prader-Willi syndrome is a complex genetic condition caused by loss of function of genes on chromosome 15. It causes hyperphagia (insatiable hunger), intellectual disability, and hormonal problems. Without strict dietary management, obesity and its complications are a major risk. Growth hormone therapy has been transformative.
Most Recent Research
BACKGROUND: Prader-Willi syndrome (PWS) is a genetic disorder associated with generalized autonomic dysfunction. Children with PWS are at increased risk of obstructive sleep apnea (OSA) and central sleep apnea (CSA), which are also associated with autonomic dysfunction and increased risk for cardiovascular disease later in life. This study aimed to investigate the autonomic control of heart rate (HR) in children with PWS. METHODS: 49 growth hormone naïve children with PWS (aged 2 months to 15 y) were individually matched for age, sex, obstructive apnea hypopnea index (OAHI), central apnea hypopnea index (CAHI) and BMI (children >2 y) with typically developing (TD) children. Multilevel modelling determined the effect of PWS on HR changes during obstructive and central respiratory events during sleep, between a 10s pre-event window, to the latter half of each respiratory event (late-event), and 15s post-event, accounting for respiratory disturbance index (OAHI + CAHI), age, arousal and event length. RESULTS: During sleep, children with PWS had a smaller percentage change in HR during obstructive events, from the pre-event to post-event (PWS: median 8.7% (IQR 3.6%,16.8%) TD: 15.6% (8.5%,25.7%, p < 0.01) and from late-event to post-event (PWS: 12.1% (6.4%,21.8%) TD: 16.8% (9.8%,29.5%), p < 0.05) phases. There was no difference between groups for central events. CONCLUSION: Our results demonstrate dampened autonomic control of HR in children with PWS. Further research is necessary to determine the implications of autonomic dysfunction in affected children on future overall health outcomes including their cardiovascular and neurocognitive health.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.